Cancer World Congress series features oncology conferences that emphasizes the dissemination of cutting-edge research findings, the propagation of novel knowledge and therapeutic paradigms, and the exploration of groundbreaking innovations in the realm of cancer care. Our global cancer conference acts as a dynamic platform for extensive discussions and idea exchanges, driving cancer research beyond conventional scientific presentations.

9^th Cancer World Congress-2025 (CWC-2025) will be held from May 22-24, 2025 in Prague, Czech Republic. The conference revolves around the theme "Precision Oncology: Harnessing Innovations in Diagnostics and Therapeutics for Optimized Cancer Treatment".

The primary aim of our cancer conferences is to offer an inclusive platform for the global cancer community, encompassing scientists, clinicians, scholars, academicians, and other healthcare experts to accelerate progress against cancer. This platform enables them to delve into and exchange their research findings across diverse topics, propelling cancer care forward and shaping the current Oncology and Cancer Biology landscape.

9^th CWC-2025 will emphasize keynote, oral, and poster presentations, enabling delegates to explore cutting-edge innovations in Oncology and engage in an interactive program. This congress presents a distinctive opportunity for young researchers to exchange novel ideas and methods, facilitating the swift advancement of new cancer treatment approaches

Delve into dynamic and engaging sessions encompassing every aspect of cancer care, from pioneering research to impactful patient management. Our 9^th Cancer World Congress-2025 runs on the theme "Precision Oncology: Harnessing Innovations in Diagnostics and Therapeutics for Optimized Cancer Treatment".

This theme focuses on emerging trends in cancer research and treatment, particularly in the field of precision medicine and personalized therapies. It encompasses various aspects such as:

• Practical Approach to Cancer Diagnosis, Staging, Prognosis and Therapy: A comprehensive program that equips participants with the knowledge and skills to effectively diagnose, stage, assess prognosis, and develop treatment plans for cancer patients.
• Genomic Medicine: Highlighting the role of genomic profiling and molecular diagnostics in identifying targeted treatments and predicting treatment outcomes.
• Immunotherapy and Immunogenomics: Exploring the latest advancements in cancer immunotherapy, including immune checkpoint inhibitors, CAR-T cell therapy, and vaccine-based approaches.
• Liquid Biopsies and Circulating Biomarkers: Examining the potential of liquid biopsies and circulating tumor DNA/RNA as non-invasive tools for cancer detection, monitoring treatment response, and detecting resistance mechanisms.
• Patient-Centric Care: Emphasizing the importance of patient-centered care, shared decision-making, and survivorship programs in improving overall cancer care outcomes.
• Artificial Intelligence and Big Data: Discussing the use of AI, machine learning, and big data analytics in cancer research, from drug discovery to patient outcomes analysis.
• Health Equity and Access: Addressing disparities in cancer care access, clinical trial participation, and healthcare outcomes across different populations and regions.

For a complete list of topics please visit our Scientific Sessions page: